Skip to content
Est. 1998 proudly celebrating our 27th year of championing American business
American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

Biodexa Pharmaceuticals Plc

  • Public · NASDAQ: BDRX
  • 11 employees
$2.5MMarket cap
11Employees
BDRXNASDAQ
2015IPO

About Biodexa Pharmaceuticals Plc

Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.

This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.

Reported figures

Financial summary

Market cap
$2.5M
NASDAQ: BDRX

15-minute delayed · data by Polygon.io

Market cap
$2.5M
Open
Day range
Prev close
Volume
IPO date
Dec 7, 2015

Market data by Polygon.io · prices are 15-minute delayed

No reviews yet. Be the first to review Biodexa Pharmaceuticals Plc.

Write a review
Explore

Similar companies

Browse all →